These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. Fujii N; Hirshman MF; Kane EM; Ho RC; Peter LE; Seifert MM; Goodyear LJ J Biol Chem; 2005 Nov; 280(47):39033-41. PubMed ID: 16186119 [TBL] [Abstract][Full Text] [Related]
4. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle. Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872 [TBL] [Abstract][Full Text] [Related]
5. Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Jørgensen SB; Treebak JT; Viollet B; Schjerling P; Vaulont S; Wojtaszewski JF; Richter EA Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E331-9. PubMed ID: 16954334 [TBL] [Abstract][Full Text] [Related]
7. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle. Ai H; Ihlemann J; Hellsten Y; Lauritzen HP; Hardie DG; Galbo H; Ploug T Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1291-300. PubMed ID: 12006359 [TBL] [Abstract][Full Text] [Related]
8. Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle. Miyamoto L; Toyoda T; Hayashi T; Yonemitsu S; Nakano M; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Ogawa Y; Inoue G; Fushiki T; Nakao K J Appl Physiol (1985); 2007 Mar; 102(3):1007-13. PubMed ID: 17122373 [TBL] [Abstract][Full Text] [Related]
9. Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering. Jørgensen NO; Kjøbsted R; Larsen MR; Birk JB; Andersen NR; Albuquerque B; Schjerling P; Miller R; Carling D; Pehmøller CK; Wojtaszewski JFP Mol Metab; 2021 Sep; 51():101259. PubMed ID: 34033941 [TBL] [Abstract][Full Text] [Related]
10. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle. Fediuc S; Gaidhu MP; Ceddia RB Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531 [TBL] [Abstract][Full Text] [Related]
12. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake. Al-Khalili L; Krook A; Zierath JR; Cartee GD Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951 [TBL] [Abstract][Full Text] [Related]
13. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling. Deshmukh AS; Treebak JT; Long YC; Viollet B; Wojtaszewski JF; Zierath JR Mol Endocrinol; 2008 May; 22(5):1105-12. PubMed ID: 18276828 [TBL] [Abstract][Full Text] [Related]
14. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Lai YC; Kviklyte S; Vertommen D; Lantier L; Foretz M; Viollet B; Hallén S; Rider MH Biochem J; 2014 Jun; 460(3):363-75. PubMed ID: 24665903 [TBL] [Abstract][Full Text] [Related]
15. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle. Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454 [TBL] [Abstract][Full Text] [Related]
16. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Hayashi T; Hirshman MF; Kurth EJ; Winder WW; Goodyear LJ Diabetes; 1998 Aug; 47(8):1369-73. PubMed ID: 9703344 [TBL] [Abstract][Full Text] [Related]
17. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. Lemieux K; Konrad D; Klip A; Marette A FASEB J; 2003 Sep; 17(12):1658-65. PubMed ID: 12958172 [TBL] [Abstract][Full Text] [Related]
18. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Bergeron R; Russell RR; Young LH; Ren JM; Marcucci M; Lee A; Shulman GI Am J Physiol; 1999 May; 276(5):E938-44. PubMed ID: 10329989 [TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo. Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]